Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Check online at for docs in your area
It eliminates the need for ongoing medication management and the associated risks of adverse drug interactions
CEO Lee stated, D&D Pharmatech continues platform-based clinical expansion across two pillars: liver disease and CNS. He added, Histological results and additional biomarker data for DD01 will be released in the second quarter of this year. During the Q&A session after the presentation, a question was raised about DD01's strategic positioning, given that recently approved GLP-1 agonists for obesity treatment, such as Wegovy and Mounjaro, are now expanding into MASH indications
Cabo Soler JR
US$ 26.41
US$ 25.99
US$ 29.84
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 24.28
US$ 24.13
US$ 20.95
